The Gut Microbiome in Women With Polycystic Ovary Syndrome
- Status
- CompletedResults none
- Why it is watched
- non-weight indication: endocrine, other_emerging
- Who it enrolls
- age 18 Years to 40 Years; female; BMI ≥27 required; conditions: PCOS; Obesity; Metabolic Syndrome
- Interventions
- dietary advice plus myo-inositol and folic acid; dietary advice plus Liraglutide Pen Injector
- Conditions
- PCOS; Obesity; Metabolic Syndrome
- Phase and size
- Phase 4 · 21 participants
- Dates
- Start 2019-02-28
Primary completion 2020-02-01 - Sponsor
- Universitaire Ziekenhuizen KU Leuven (Other)
- Last checked
- Sep 13, 2026
01Endpoints
What the trial will measure
- weight loss32 weeks
02Eligibility
Who can take part
Inclusion Criteria: * PCOS according to ROtterdam criteria * BMI ≥ 27 kg/m2 and at risk of metabolic syndrome or BMI ≥ 30 kg/m2 Exclusion Criteria: * pregnancy * pancreatitis (in the past) * oral contraceptive pill use * inflammatory bowel disease * auto-immune disease * immuno-modulatory drugs * antidiabetic drugs * anti-inflammatory drugs
03Change log
Registry changes
No changes recorded since the trial was added.